Archive - March 2022
FDA Approves Tlando (testosterone undecanoate) for Male Hypogonadism
Cell & Gene Therapy: High stakes and high hopes for healthcare
Sanofi and Regeneron share positive trial results for patients with uncontrolled prurigo nodularis
Lebrikizumab achieves skin clearance in pivotal phase 3 atopic dermatitis trials
Cormedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for Defencath
New report on tackling ethnic inequalities in diabetes care
Sanofi and IGM Biosciences team up to develop antibody agonists
Caught COVID? Here’s What You Should And Shouldn’t Do When Self-Isolation Isn’t Mandatory